<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">3804</id>
  <title>T3D3750</title>
  <common-name>Aurovertin B</common-name>
  <description>Aurovertin B is an exogenous solid with the formula C25H32O8 and an average molecular weight of 460.52 g/mol. Aurovertin B belongs to the carbohydrates and carbohydrate conjugates, a subclass of organooxygen compounds within the organic compounds.

This compound acts as a mixed, noncompetitive inhibitor of both ATP synthesis and ATP hydrolysis. It targets the proton-pumping F1F0-ATP synthase, which is responsible for the terminal step of oxidative phosphorylation. The recorded protein targets include the mitochondrial ATP synthase F(1) complex subunits alpha (ATP5F1A), beta (ATP5F1B), and gamma (ATP5F1C). Specifically, aurovertins are believed to bind with varying affinity to two of the three beta subunits on sites in a cleft between the C-terminal and nucleotide-binding domains to inhibit the enzyme.</description>
  <cas>55350-03-3</cas>
  <pubchem-id>6441012</pubchem-id>
  <chemical-formula>C25H32O8</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Oral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Aurovertins are a mixed, noncompetitive inhibitors of both ATP hydrolysis and synthesis. They do this by inhibiting the proton-pumping F1F0-ATP synthase by binding to beta-subunits in its F1 catalytic sector. F1F0-ATP synthase is responsible for the terminal step of oxidative phosphorylation. Each ATP synthase complex has three beta subunits, and aurovertins are believed to bind with varying affinity to two subunits on sites in a cleft between the nucleotide-binding and C-terminal domains, thus preventing closure of the catalytic interfaces necessary for the cyclic interconversion of catalytic sites.
(A3032, A3033, A3034)</mechanism-of-toxicity>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>Aurovertin B is a mycotoxin and antibiotic produced by the fungus Calcarisporium arbuscula. (A3002)</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2010-05-12T17:30:02Z</created-at>
  <updated-at type="dateTime">2026-04-05T13:12:47Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB07394</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[H]/C(=C(/[H])\C(\[H])=C(/[H])C1=C(C)C(OC)=CC(=O)O1)/C(/[H])=C(\[H])C1OC2(C)C(CC)OC(C)(C2OC(C)=O)C1O</moldb-smiles>
  <moldb-formula>C25H32O8</moldb-formula>
  <moldb-inchi>InChI=1S/C25H32O8/c1-7-20-24(4)23(30-16(3)26)25(5,33-20)22(28)18(32-24)13-11-9-8-10-12-17-15(2)19(29-6)14-21(27)31-17/h8-14,18,20,22-23,28H,7H2,1-6H3/b9-8+,12-10+,13-11+</moldb-inchi>
  <moldb-inchikey>QXCOFYWOWZJFEA-YIDQAKLOSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">460.523</moldb-average-mass>
  <moldb-mono-mass type="decimal">460.20971799</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM002718</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00071822</susdat-id>
  <iupac nil="true"/>
  <moldb-polar-surface-area>100.52000000000002</moldb-polar-surface-area>
  <moldb-refractivity>125.50259999999999</moldb-refractivity>
  <moldb-polarizability>50.466648172042156</moldb-polarizability>
  <moldb-rotatable-bond-count>8</moldb-rotatable-bond-count>
  <moldb-acceptor-count>6</moldb-acceptor-count>
  <moldb-donor-count>1</moldb-donor-count>
  <moldb-pka-strongest-acidic>12.9124340730191</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-3.7119013364614455</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>3</moldb-number-of-rings>
  <moldb-alogps-logp>4.02</moldb-alogps-logp>
  <moldb-alogps-logs>-4.62</moldb-alogps-logs>
  <moldb-alogps-solubility>1.10e-02 g/l</moldb-alogps-solubility>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic oxygen compounds</superklass>
  <klass>Organooxygen compounds</klass>
  <subklass>Carbohydrates and carbohydrate conjugates</subklass>
  <paper-count type="integer">23</paper-count>
  <sync-id>CED0017662</sync-id>
  <structure-inchikey>QXCOFYWOWZJFEA-YIDQAKLOSA-N</structure-inchikey>
  <structure-fingerprint>20000000000000000800040000000001000000000000000000080400000480000020002000020000000000000000800000000000080000000000000000000004000000000008000000000000000000020800000000300000000000000000000000000010000001040000000100000000000001000000000000000000004500030000048020000000000200200000180000000000000004008000000400020000000008040000000000000080000000000000000020100000000000000000080000000000000900800000000000000000000000000002000100000000000000000010010000000000040000000008400000100000021000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAIwAAAIABBgA4AAAAAwEEBgA4AAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:00:54Z</structure-indexed-at>
</compound>
